The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives

Jing Wang,Teng Yang,Huang Chen,Yun-Nan Xu,Li-Fang Yu,Ting Liu,Jie Tang,Zhengfang Yi,Cai-Guang Yang,Wei Xue,Fan Yang
DOI: https://doi.org/10.1016/j.ejmech.2017.01.012
IF: 7.088
2017-01-01
European Journal of Medicinal Chemistry
Abstract:A series of novel 9, 13-disubstituted berberine derivatives have been synthesized and evaluated for the antibacterial activities against Staphylococcus aureus, including Newman strain and multidrug-resistant strains (NRS-1, NRS-70, NRS-100, NRS-108, and NRS-271). Compound 20 shows the most potent activity against the growth of Newman strain, with a MIC value of 0.78 μg/mL, which is comparable with the positive control vancomycin. In addition, compound 20, 21, and 33 are highly antistaphylococcal active against five strains of multidrug-resistant S. aureus, with MIC values of 0.78–1.56 μg/mL. Of note, theses antibacterial active compounds have no obvious toxicity to the viability of human fibroblast (HAF) cells at the MIC concentration.
What problem does this paper attempt to address?